AI
FHTX icon

Alphabet Inc’s Foghorn Therapeutics FHTX Stock Holding History

Alphabet Inc’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-500,901
Closed -$2.45M – 33
2025
Q3 		$2.45M Hold
500,901
– – 0.1% 23
2025
Q2 		$2.35M Hold
500,901
– – 0.11% 23
2025
Q1 		$1.83M Hold
500,901
– – 0.12% 25
2024
Q4 		$2.36M Hold
500,901
– – 0.14% 22
2024
Q3 		$4.66M Hold
500,901
– – 0.25% 23
2024
Q2 		$2.88M Hold
500,901
– – 0.15% 24
2024
Q1 		$3.36M Hold
500,901
– – 0.13% 29
2023
Q4 		$3.23M Hold
500,901
– – 0.15% 27
2023
Q3 		$2.5M Hold
500,901
– – 0.16% 28
2023
Q2 		$3.53M Hold
500,901
– – 0.19% 27
2023
Q1 		$3.11M Hold
500,901
– – 0.17% 28
2022
Q4 		$3.2M Hold
500,901
– – 0.19% 30
2022
Q3 		$4.3M Hold
500,901
– – 0.22% 33
2022
Q2 		$6.81M Hold
500,901
– – 0.37% 29
2022
Q1 		$7.63M Hold
500,901
– – 0.25% 35
2021
Q4 		$11.5M Hold
500,901
– – 0.28% 34
2021
Q3 		$6.98M Hold
500,901
– – 0.17% 34
2021
Q2 		$5.34M Hold
500,901
– – 0.11% 30
2021
Q1 		$6.6M Hold
500,901
– – 0.27% 26
2020
Q4 		$10.2M Buy
+500,901
New +$9.6M 0.49% 21

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Alphabet Inc's FHTX Position: Q4 2025 in Review

Alphabet Inc sold out of Foghorn Therapeutics (FHTX) in Q4 2025, closing a stake of 500,901 shares — an estimated $2.45M sold.

Alphabet Inc first reported a position in FHTX in Q4 2020 and held it in 20 quarters. The position peaked at $11.5M in Q4 2021. 93 funds tracked by Wall St. Rank hold FHTX as of Q4 2025.

  • Alphabet Inc reported no remaining Foghorn Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Alphabet Inc sold 500,901 Foghorn Therapeutics shares in Q4 2025, an estimated $2.45M.
  • Alphabet Inc first reported a position in Foghorn Therapeutics in Q4 2020 and held it in 20 quarters.
  • Alphabet Inc's Foghorn Therapeutics position peaked at $11.5M in Q4 2021.
  • 93 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q4 2025.

Based on Alphabet Inc's 13F filing for Q4 2025, filed 13 Feb 2026.